Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/16/2010EP2196199A1 Treatment of phantom phenomena
06/16/2010EP2196197A1 Antiviral patch
06/16/2010EP2196195A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
06/16/2010EP2196099A1 Immuno-nutritional composition
06/16/2010EP2195656A2 Human t2r bitterness receptors and uses thereof
06/16/2010EP2195462A1 Prediction of sleep parameter and response to sleep-inducing compound based on per3 vntr genotype
06/16/2010EP2195430A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles
06/16/2010EP2195429A2 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality
06/16/2010EP2195425A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2195326A1 Nucleoside derivatives as inhibitors of viral polymerases
06/16/2010EP2195323A2 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
06/16/2010EP2195322A1 Imidazoý1,2-a¨pyrimidine derivatives for treating diseases such as diabetes
06/16/2010EP2195320A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/16/2010EP2195319A1 Valomaciclovir polymorphs
06/16/2010EP2195318A2 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP2195315A1 Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11 -hydroxysteroid dehydrogenase type-1
06/16/2010EP2195314A1 Disubstituted alkyl-8-azabicyclo [3.2.1.]octane compounds as mu opioid receptor antagonists
06/16/2010EP2195313A1 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/16/2010EP2195312A1 Pyridine derivatives useful as glucokinase activators
06/16/2010EP2195311A1 Pyridine derivatives as s1p1/edg1 receptor modulators
06/16/2010EP2195309A2 Polymorphs of esomeprazole salts
06/16/2010EP2195308A2 Antiinfective flavononol compounds and methods of use thereof
06/16/2010EP2195307A1 Piperazine derivative having affinity for the histamine h3 receptor
06/16/2010EP2195304A2 Acetamide derivatives as glucokinase activators, their process and medicinal applications
06/16/2010EP2195301A1 Crystalline chemotherapeutic
06/16/2010EP2195300A1 Crystalline chemotherapeutic
06/16/2010EP2195299A1 Crystalline chemotherapeutic
06/16/2010EP2195298A1 Crystalline indazole-derived chemotherepeutic
06/16/2010EP2195297A1 Crystalline chemotherapeutic
06/16/2010EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists
06/16/2010EP2195292A1 Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer
06/16/2010EP2195289A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists
06/16/2010EP2195287A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
06/16/2010EP2195285A1 Acetamide stereoisomer
06/16/2010EP2195035A1 High concentration chitosan-nucleic acid polyplex compositions
06/16/2010EP2195030A1 Isoflavone formulation
06/16/2010EP2195029A2 Treatment and prevention of neurodegenerative diseases
06/16/2010EP2195027A1 Methods of treating neurological autoimmune disorders with cyclophosphamide
06/16/2010EP2195003A1 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
06/16/2010EP2194996A2 Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts
06/16/2010EP2194991A1 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
06/16/2010EP2194988A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
06/16/2010EP2194987A2 Novel stat3 pathway inhibitors and cancer stem cell inhibitors
06/16/2010EP2194986A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
06/16/2010EP2194985A1 Antimalarial compounds with flexible side-chains
06/16/2010EP2194984A1 Medicament for treating or preventing proteinuria
06/16/2010EP2194983A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010EP2194982A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010EP2194980A1 Fluoro-containing derivatives of hydrogented pyridoý4,3-b¨indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
06/16/2010EP2194979A1 Treatment of cns and pain disorders
06/16/2010EP2194976A1 Hepatitis c antiviral compositions and methods
06/16/2010EP2194975A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-ß DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS
06/16/2010EP2194974A1 Anti-bacterial pyrocatechols and related methods
06/16/2010EP2194970A2 Enhancement of the efficacy of therapeutic proteins
06/16/2010EP2194965A2 Non-aqueous pharmaceutical compositions
06/16/2010EP2194787A1 Vegfr inhibitors containing a zinc binding moiety
06/16/2010EP2194780A1 Method of treating glaucoma using rasagiline
06/16/2010EP2035379B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/16/2010EP2029580B1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
06/16/2010EP2010536B1 Imidazo [1, 2-b]pyridazines, their processes of preparation and their use as gaba receptor ligands
06/16/2010EP1981858B1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
06/16/2010EP1963311B1 Chromane substituted benzimidazoles and their use as acid pump inhibitors
06/16/2010EP1914229B1 Novel cercosporamide derivative
06/16/2010EP1863802B1 Substituted piperidines as renin inhibitors
06/16/2010EP1848448B1 Use of a bacterial lysate for the prevention of tuberculosis relapse
06/16/2010EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
06/16/2010EP1791543B1 Triazolophthalazines
06/16/2010EP1784409B1 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
06/16/2010EP1756085B1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010EP1633211B1 Hot liquid fiber product
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010EP1364010B1 Immunomodulatory polynucleotides and methods of using the same
06/16/2010EP1349857B1 Purine derivatives as purinergic receptor antagonists
06/16/2010EP1307233B1 Therapeutic polyanhydride compounds for drug delivery
06/16/2010EP1091924B1 Novel retinoids and use thereof
06/16/2010EP0938320B1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
06/16/2010CN1997361B Antitumor agent
06/16/2010CN1994296B Pharmaceutical composition containing simvastatin
06/16/2010CN1993118B Aqueous eye drops with accelerated intraocular migration permeability
06/16/2010CN1989141B Bicyclic heterocycles as HIV integrase inhibitors
06/16/2010CN1982308B Substituted pyrazoles
06/16/2010CN1980629B Method of decreasing sebum production and pore size
06/16/2010CN1951376B Novel medical usage of protocatechualdehyde
06/16/2010CN1938307B 9-substituted 8-oxoadenine compound
06/16/2010CN1930162B Tetrahydropyridoindole derivatives
06/16/2010CN1925855B Compounds and methods for development of Ret modulators
06/16/2010CN1922189B Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor
06/16/2010CN1921865B Use of meloxicam for the treatment of respiratory diseases in pigs
06/16/2010CN1921847B Amino alcohol compound
06/16/2010CN1918512B Digital still camera with audio decoding and coding
06/16/2010CN1917779B Nutritional composiition for improving skin condition and preventing skin diseases
06/16/2010CN1915997B New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
06/16/2010CN1910145B Pyrrolidine derivatives acting as CCR3-receptor antagonists
06/16/2010CN1902165B Synthesis of optically pure (R)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide
1 ... 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 ... 7860